Biontech, a German company that developed a new coronavirus vaccine with American pharmaceutical giant Pfizer, said at a press conference on the 22nd that the current vaccine is very likely to be effective against mutated viruses that are spreading in the United Kingdom. However, he acknowledged that a vaccine for the mutated virus could be developed in about 6 weeks if necessary.
Biontech, a German company that developed a new coronavirus vaccine with American pharmaceutical giant Pfizer, held a press conference online on the 22nd.
In this, CEO Wool Shahin said that the mutated new coronavirus, which is spreading in the United Kingdom, is "scientifically very likely to be treated with current vaccines." I did.
However, he said, "It will take about two weeks to collect the data," and he said that he would carefully judge the effectiveness.
On top of that, CEO Shahin also acknowledged that if an effective vaccine against a mutated virus is needed, it can be developed in about six weeks.
In addition, Ezrem Turegi CMO = Chief Medical Officer said that the safety and efficacy of vaccines are being carefully examined in Japan as well, saying, "I can't answer the future schedule, but it will be swift in Japan as well. I hope the procedure will proceed. "